Literature DB >> 7009782

Initial rate studies of hydrolysis and acyl migration in methylprednisolone 21-hemisuccinate and 17-hemisuccinate.

B D Anderson, V Taphouse.   

Abstract

The degradation of methylprednisolone 21-succinate in aqueous solution was examined as a function of pH at 25 degrees by monitoring the initial rates of product formation. In addition to hydrolysis, acyl migration fro the 21-hydroxyl group was found to be an important reaction. The 17-succinate was isolated, and its decomposition to the 21-succinate was followed by the initial rate method. Direct hydrolysis of the 17-ester was much slower than the 17 leads to 21 acyl migration under alkaline conditions. From the rate constants for the forward and reverse acyl migration, it may be concluded that the 21-ester is thermodynamically more stable, even though its alkaline hydrolysis is faster. The hydrolysis of the 21-ester and the reversible rearrangement are subject to intramolecular catalysis by the terminal carboxyl group, for which a kinetic pKa value of 4.5-4.6 was estimated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7009782     DOI: 10.1002/jps.2600700217

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

1.  The effect of bulking agent on the solid-state stability of freeze-dried methylprednisolone sodium succinate.

Authors:  B D Herman; B D Sinclair; N Milton; S L Nail
Journal:  Pharm Res       Date:  1994-10       Impact factor: 4.200

2.  Influence of route of administration on the pharmacokinetics of methylprednisolone.

Authors:  E J Antal; C E Wright; W R Gillespie; K S Albert
Journal:  J Pharmacokinet Biopharm       Date:  1983-12

3.  Pharmacokinetics of methylprednisolone after intravenous and intramuscular administration in rats.

Authors:  Anasuya Hazra; Nancy Pyszczynski; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Biopharm Drug Dispos       Date:  2007-09       Impact factor: 1.627

4.  Fabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoids.

Authors:  Yuval Avnir; Keren Turjeman; Deborah Tulchinsky; Alex Sigal; Pablo Kizelsztein; Dina Tzemach; Alberto Gabizon; Yechezkel Barenholz
Journal:  PLoS One       Date:  2011-10-06       Impact factor: 3.240

5.  Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases.

Authors:  Keren Turjeman; Yaelle Bavli; Pablo Kizelsztein; Yaelle Schilt; Nahum Allon; Tamar Blumenfeld Katzir; Efrat Sasson; Uri Raviv; Haim Ovadia; Yechezkel Barenholz
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

6.  Lung targeted liposomes for treating ARDS.

Authors:  Sivan Arber Raviv; Mohammed Alyan; Egor Egorov; Agam Zano; Moshit Yaskin Harush; Calvin Pieters; Hila Korach-Rechtman; Adi Saadya; Galoz Kaneti; Igor Nudelman; Shai Farkash; Ofri Doppelt Flikshtain; Lucy N Mekies; Lilach Koren; Yoav Gal; Ella Dor; Janna Shainsky; Jeny Shklover; Yochai Adir; Avi Schroeder
Journal:  J Control Release       Date:  2022-03-28       Impact factor: 11.467

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.